Gret-39 Jun 2026

: These instruments are popular among beginners and hobbyists for their portability and ease of use.

A class of compounds targeting the GPR-189 receptor (the putative GRET-39 receptor in muscle) is in lead optimization. These oral agents aim to competitively inhibit GRET-39 binding, allowing GLUT4 to function normally. Early toxicity studies show mild gastrointestinal side effects, likely due to on-target effects in gut smooth muscle. GRET-39

A simple ELISA kit for human GRET-39 is now commercially available for research use, and several diagnostic companies are pursuing FDA clearance for a clinical assay. : These instruments are popular among beginners and